Global Circulating Tumor Cells (CTC) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 287790
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Circulating Tumor Cells (CTC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Circulating Tumor Cells (CTC) market size is estimated to be worth US$ 1109.7 million in 2021 and is forecast to a readjusted size of USD 3866.9 million by 2028 with a CAGR of 19.5% during review period. Tumorigenesis Research accounting for % of the Circulating Tumor Cells (CTC) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ex-Vivo Positive Selection segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Circulating Tumor Cells (CTC) include AdnaGen, Apocell, Biocep, Canopus Bioscience, and Creatv Microtech, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Circulating Tumor Cells (CTC) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Ex-Vivo Positive Selection

In-Vivo Positive Selection

Negative Selection

Microchips & Single Spiral Micro Channel

Market segment by Application, can be divided into

Tumorigenesis Research

Emt Biomarkers Development

Cancer Stem Cell Research

Others

Market segment by players, this report covers

AdnaGen

Apocell

Biocep

Canopus Bioscience

Creatv Microtech

Ikonisys

IV Diagnostics

Miltenyi Biotech

Nanostring Technologies

Rarecells Diagnostics

Vitatex

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Circulating Tumor Cells (CTC) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Circulating Tumor Cells (CTC), with revenue, gross margin and global market share of Circulating Tumor Cells (CTC) from 2019 to 2022.

Chapter 3, the Circulating Tumor Cells (CTC) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Circulating Tumor Cells (CTC) market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Circulating Tumor Cells (CTC) research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Circulating Tumor Cells (CTC)

1.2 Classification of Circulating Tumor Cells (CTC) by Type

1.2.1 Overview: Global Circulating Tumor Cells (CTC) Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Type in 2021

1.2.3 Ex-Vivo Positive Selection

1.2.4 In-Vivo Positive Selection

1.2.5 Negative Selection

1.2.6 Microchips & Single Spiral Micro Channel

1.3 Global Circulating Tumor Cells (CTC) Market by Application

1.3.1 Overview: Global Circulating Tumor Cells (CTC) Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Tumorigenesis Research

1.3.3 Emt Biomarkers Development

1.3.4 Cancer Stem Cell Research

1.3.5 Others

1.4 Global Circulating Tumor Cells (CTC) Market Size & Forecast

1.5 Global Circulating Tumor Cells (CTC) Market Size and Forecast by Region

1.5.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Circulating Tumor Cells (CTC) Market Size by Region, (2017-2022)

1.5.3 North America Circulating Tumor Cells (CTC) Market Size and Prospect (2017-2028)

1.5.4 Europe Circulating Tumor Cells (CTC) Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Circulating Tumor Cells (CTC) Market Size and Prospect (2017-2028)

1.5.6 South America Circulating Tumor Cells (CTC) Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Circulating Tumor Cells (CTC) Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Circulating Tumor Cells (CTC) Market Drivers

1.6.2 Circulating Tumor Cells (CTC) Market Restraints

1.6.3 Circulating Tumor Cells (CTC) Trends Analysis

2 Company Profiles

2.1 AdnaGen

2.1.1 AdnaGen Details

2.1.2 AdnaGen Major Business

2.1.3 AdnaGen Circulating Tumor Cells (CTC) Product and Solutions

2.1.4 AdnaGen Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AdnaGen Recent Developments and Future Plans

2.2 Apocell

2.2.1 Apocell Details

2.2.2 Apocell Major Business

2.2.3 Apocell Circulating Tumor Cells (CTC) Product and Solutions

2.2.4 Apocell Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Apocell Recent Developments and Future Plans

2.3 Biocep

2.3.1 Biocep Details

2.3.2 Biocep Major Business

2.3.3 Biocep Circulating Tumor Cells (CTC) Product and Solutions

2.3.4 Biocep Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Biocep Recent Developments and Future Plans

2.4 Canopus Bioscience

2.4.1 Canopus Bioscience Details

2.4.2 Canopus Bioscience Major Business

2.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Product and Solutions

2.4.4 Canopus Bioscience Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Canopus Bioscience Recent Developments and Future Plans

2.5 Creatv Microtech

2.5.1 Creatv Microtech Details

2.5.2 Creatv Microtech Major Business

2.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Product and Solutions

2.5.4 Creatv Microtech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Creatv Microtech Recent Developments and Future Plans

2.6 Ikonisys

2.6.1 Ikonisys Details

2.6.2 Ikonisys Major Business

2.6.3 Ikonisys Circulating Tumor Cells (CTC) Product and Solutions

2.6.4 Ikonisys Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Ikonisys Recent Developments and Future Plans

2.7 IV Diagnostics

2.7.1 IV Diagnostics Details

2.7.2 IV Diagnostics Major Business

2.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Product and Solutions

2.7.4 IV Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 IV Diagnostics Recent Developments and Future Plans

2.8 Miltenyi Biotech

2.8.1 Miltenyi Biotech Details

2.8.2 Miltenyi Biotech Major Business

2.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Product and Solutions

2.8.4 Miltenyi Biotech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Miltenyi Biotech Recent Developments and Future Plans

2.9 Nanostring Technologies

2.9.1 Nanostring Technologies Details

2.9.2 Nanostring Technologies Major Business

2.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Product and Solutions

2.9.4 Nanostring Technologies Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Nanostring Technologies Recent Developments and Future Plans

2.10 Rarecells Diagnostics

2.10.1 Rarecells Diagnostics Details

2.10.2 Rarecells Diagnostics Major Business

2.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Product and Solutions

2.10.4 Rarecells Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Rarecells Diagnostics Recent Developments and Future Plans

2.11 Vitatex

2.11.1 Vitatex Details

2.11.2 Vitatex Major Business

2.11.3 Vitatex Circulating Tumor Cells (CTC) Product and Solutions

2.11.4 Vitatex Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Vitatex Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Circulating Tumor Cells (CTC) Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Circulating Tumor Cells (CTC) Players Market Share in 2021

3.2.2 Top 10 Circulating Tumor Cells (CTC) Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Circulating Tumor Cells (CTC) Players Head Office, Products and Services Provided

3.4 Circulating Tumor Cells (CTC) Mergers & Acquisitions

3.5 Circulating Tumor Cells (CTC) New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Type (2017-2022)

4.2 Global Circulating Tumor Cells (CTC) Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2017-2022)

5.2 Global Circulating Tumor Cells (CTC) Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Circulating Tumor Cells (CTC) Revenue by Type (2017-2028)

6.2 North America Circulating Tumor Cells (CTC) Revenue by Application (2017-2028)

6.3 North America Circulating Tumor Cells (CTC) Market Size by Country

6.3.1 North America Circulating Tumor Cells (CTC) Revenue by Country (2017-2028)

6.3.2 United States Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

6.3.3 Canada Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

6.3.4 Mexico Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Circulating Tumor Cells (CTC) Revenue by Type (2017-2028)

7.2 Europe Circulating Tumor Cells (CTC) Revenue by Application (2017-2028)

7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country

7.3.1 Europe Circulating Tumor Cells (CTC) Revenue by Country (2017-2028)

7.3.2 Germany Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

7.3.3 France Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

7.3.5 Russia Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

7.3.6 Italy Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Type (2017-2028)

8.2 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Application (2017-2028)

8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region

8.3.1 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Region (2017-2028)

8.3.2 China Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

8.3.3 Japan Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

8.3.4 South Korea Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

8.3.5 India Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

8.3.7 Australia Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Circulating Tumor Cells (CTC) Revenue by Type (2017-2028)

9.2 South America Circulating Tumor Cells (CTC) Revenue by Application (2017-2028)

9.3 South America Circulating Tumor Cells (CTC) Market Size by Country

9.3.1 South America Circulating Tumor Cells (CTC) Revenue by Country (2017-2028)

9.3.2 Brazil Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

9.3.3 Argentina Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Type (2017-2028)

10.2 Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Application (2017-2028)

10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country

10.3.1 Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Country (2017-2028)

10.3.2 Turkey Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

10.3.4 UAE Circulating Tumor Cells (CTC) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Circulating Tumor Cells (CTC) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Circulating Tumor Cells (CTC) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Circulating Tumor Cells (CTC) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Circulating Tumor Cells (CTC) Revenue (USD Million) by Region (2017-2022)

Table 5. Global Circulating Tumor Cells (CTC) Revenue Market Share by Region (2023-2028)

Table 6. AdnaGen Corporate Information, Head Office, and Major Competitors

Table 7. AdnaGen Major Business

Table 8. AdnaGen Circulating Tumor Cells (CTC) Product and Solutions

Table 9. AdnaGen Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Apocell Corporate Information, Head Office, and Major Competitors

Table 11. Apocell Major Business

Table 12. Apocell Circulating Tumor Cells (CTC) Product and Solutions

Table 13. Apocell Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Biocep Corporate Information, Head Office, and Major Competitors

Table 15. Biocep Major Business

Table 16. Biocep Circulating Tumor Cells (CTC) Product and Solutions

Table 17. Biocep Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Canopus Bioscience Corporate Information, Head Office, and Major Competitors

Table 19. Canopus Bioscience Major Business

Table 20. Canopus Bioscience Circulating Tumor Cells (CTC) Product and Solutions

Table 21. Canopus Bioscience Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Creatv Microtech Corporate Information, Head Office, and Major Competitors

Table 23. Creatv Microtech Major Business

Table 24. Creatv Microtech Circulating Tumor Cells (CTC) Product and Solutions

Table 25. Creatv Microtech Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Ikonisys Corporate Information, Head Office, and Major Competitors

Table 27. Ikonisys Major Business

Table 28. Ikonisys Circulating Tumor Cells (CTC) Product and Solutions

Table 29. Ikonisys Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. IV Diagnostics Corporate Information, Head Office, and Major Competitors

Table 31. IV Diagnostics Major Business

Table 32. IV Diagnostics Circulating Tumor Cells (CTC) Product and Solutions

Table 33. IV Diagnostics Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Miltenyi Biotech Corporate Information, Head Office, and Major Competitors

Table 35. Miltenyi Biotech Major Business

Table 36. Miltenyi Biotech Circulating Tumor Cells (CTC) Product and Solutions

Table 37. Miltenyi Biotech Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Nanostring Technologies Corporate Information, Head Office, and Major Competitors

Table 39. Nanostring Technologies Major Business

Table 40. Nanostring Technologies Circulating Tumor Cells (CTC) Product and Solutions

Table 41. Nanostring Technologies Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Rarecells Diagnostics Corporate Information, Head Office, and Major Competitors

Table 43. Rarecells Diagnostics Major Business

Table 44. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product and Solutions

Table 45. Rarecells Diagnostics Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Vitatex Corporate Information, Head Office, and Major Competitors

Table 47. Vitatex Major Business

Table 48. Vitatex Circulating Tumor Cells (CTC) Product and Solutions

Table 49. Vitatex Circulating Tumor Cells (CTC) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Global Circulating Tumor Cells (CTC) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 51. Global Circulating Tumor Cells (CTC) Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 52. Breakdown of Circulating Tumor Cells (CTC) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Circulating Tumor Cells (CTC) Players Head Office, Products and Services Provided

Table 54. Circulating Tumor Cells (CTC) Mergers & Acquisitions in the Past Five Years

Table 55. Circulating Tumor Cells (CTC) New Entrants and Expansion Plans

Table 56. Global Circulating Tumor Cells (CTC) Revenue (USD Million) by Type (2017-2022)

Table 57. Global Circulating Tumor Cells (CTC) Revenue Share by Type (2017-2022)

Table 58. Global Circulating Tumor Cells (CTC) Revenue Forecast by Type (2023-2028)

Table 59. Global Circulating Tumor Cells (CTC) Revenue by Application (2017-2022)

Table 60. Global Circulating Tumor Cells (CTC) Revenue Forecast by Application (2023-2028)

Table 61. North America Circulating Tumor Cells (CTC) Revenue by Type (2017-2022) & (USD Million)

Table 62. North America Circulating Tumor Cells (CTC) Revenue by Type (2023-2028) & (USD Million)

Table 63. North America Circulating Tumor Cells (CTC) Revenue by Application (2017-2022) & (USD Million)

Table 64. North America Circulating Tumor Cells (CTC) Revenue by Application (2023-2028) & (USD Million)

Table 65. North America Circulating Tumor Cells (CTC) Revenue by Country (2017-2022) & (USD Million)

Table 66. North America Circulating Tumor Cells (CTC) Revenue by Country (2023-2028) & (USD Million)

Table 67. Europe Circulating Tumor Cells (CTC) Revenue by Type (2017-2022) & (USD Million)

Table 68. Europe Circulating Tumor Cells (CTC) Revenue by Type (2023-2028) & (USD Million)

Table 69. Europe Circulating Tumor Cells (CTC) Revenue by Application (2017-2022) & (USD Million)

Table 70. Europe Circulating Tumor Cells (CTC) Revenue by Application (2023-2028) & (USD Million)

Table 71. Europe Circulating Tumor Cells (CTC) Revenue by Country (2017-2022) & (USD Million)

Table 72. Europe Circulating Tumor Cells (CTC) Revenue by Country (2023-2028) & (USD Million)

Table 73. Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Type (2017-2022) & (USD Million)

Table 74. Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Type (2023-2028) & (USD Million)

Table 75. Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Application (2017-2022) & (USD Million)

Table 76. Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Application (2023-2028) & (USD Million)

Table 77. Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Region (2017-2022) & (USD Million)

Table 78. Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Region (2023-2028) & (USD Million)

Table 79. South America Circulating Tumor Cells (CTC) Revenue by Type (2017-2022) & (USD Million)

Table 80. South America Circulating Tumor Cells (CTC) Revenue by Type (2023-2028) & (USD Million)

Table 81. South America Circulating Tumor Cells (CTC) Revenue by Application (2017-2022) & (USD Million)

Table 82. South America Circulating Tumor Cells (CTC) Revenue by Application (2023-2028) & (USD Million)

Table 83. South America Circulating Tumor Cells (CTC) Revenue by Country (2017-2022) & (USD Million)

Table 84. South America Circulating Tumor Cells (CTC) Revenue by Country (2023-2028) & (USD Million)

Table 85. Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Type (2017-2022) & (USD Million)

Table 86. Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Type (2023-2028) & (USD Million)

Table 87. Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Application (2017-2022) & (USD Million)

Table 88. Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Application (2023-2028) & (USD Million)

Table 89. Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Country (2017-2022) & (USD Million)

Table 90. Middle East & Africa Circulating Tumor Cells (CTC) Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Circulating Tumor Cells (CTC) Picture

Figure 2. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type in 2021

Figure 3. Ex-Vivo Positive Selection

Figure 4. In-Vivo Positive Selection

Figure 5. Negative Selection

Figure 6. Microchips & Single Spiral Micro Channel

Figure 7. Circulating Tumor Cells (CTC) Revenue Market Share by Application in 2021

Figure 8. Tumorigenesis Research Picture

Figure 9. Emt Biomarkers Development Picture

Figure 10. Cancer Stem Cell Research Picture

Figure 11. Others Picture

Figure 12. Global Circulating Tumor Cells (CTC) Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Circulating Tumor Cells (CTC) Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Circulating Tumor Cells (CTC) Revenue Market Share by Region (2017-2028)

Figure 15. Global Circulating Tumor Cells (CTC) Revenue Market Share by Region in 2021

Figure 16. North America Circulating Tumor Cells (CTC) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Circulating Tumor Cells (CTC) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Circulating Tumor Cells (CTC) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Circulating Tumor Cells (CTC) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Circulating Tumor Cells (CTC) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Circulating Tumor Cells (CTC) Market Drivers

Figure 22. Circulating Tumor Cells (CTC) Market Restraints

Figure 23. Circulating Tumor Cells (CTC) Market Trends

Figure 24. AdnaGen Recent Developments and Future Plans

Figure 25. Apocell Recent Developments and Future Plans

Figure 26. Biocep Recent Developments and Future Plans

Figure 27. Canopus Bioscience Recent Developments and Future Plans

Figure 28. Creatv Microtech Recent Developments and Future Plans

Figure 29. Ikonisys Recent Developments and Future Plans

Figure 30. IV Diagnostics Recent Developments and Future Plans

Figure 31. Miltenyi Biotech Recent Developments and Future Plans

Figure 32. Nanostring Technologies Recent Developments and Future Plans

Figure 33. Rarecells Diagnostics Recent Developments and Future Plans

Figure 34. Vitatex Recent Developments and Future Plans

Figure 35. Global Circulating Tumor Cells (CTC) Revenue Share by Players in 2021

Figure 36. Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 37. Global Top 3 Players Circulating Tumor Cells (CTC) Revenue Market Share in 2021

Figure 38. Global Top 10 Players Circulating Tumor Cells (CTC) Revenue Market Share in 2021

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 40. Global Circulating Tumor Cells (CTC) Revenue Share by Type in 2021

Figure 41. Global Circulating Tumor Cells (CTC) Market Share Forecast by Type (2023-2028)

Figure 42. Global Circulating Tumor Cells (CTC) Revenue Share by Application in 2021

Figure 43. Global Circulating Tumor Cells (CTC) Market Share Forecast by Application (2023-2028)

Figure 44. North America Circulating Tumor Cells (CTC) Sales Market Share by Type (2017-2028)

Figure 45. North America Circulating Tumor Cells (CTC) Sales Market Share by Application (2017-2028)

Figure 46. North America Circulating Tumor Cells (CTC) Revenue Market Share by Country (2017-2028)

Figure 47. United States Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Canada Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Mexico Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Europe Circulating Tumor Cells (CTC) Sales Market Share by Type (2017-2028)

Figure 51. Europe Circulating Tumor Cells (CTC) Sales Market Share by Application (2017-2028)

Figure 52. Europe Circulating Tumor Cells (CTC) Revenue Market Share by Country (2017-2028)

Figure 53. Germany Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. France Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. United Kingdom Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Russia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Italy Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Asia-Pacific Circulating Tumor Cells (CTC) Sales Market Share by Type (2017-2028)

Figure 59. Asia-Pacific Circulating Tumor Cells (CTC) Sales Market Share by Application (2017-2028)

Figure 60. Asia-Pacific Circulating Tumor Cells (CTC) Revenue Market Share by Region (2017-2028)

Figure 61. China Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South Korea Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Circulating Tumor Cells (CTC) Sales Market Share by Type (2017-2028)

Figure 68. South America Circulating Tumor Cells (CTC) Sales Market Share by Application (2017-2028)

Figure 69. South America Circulating Tumor Cells (CTC) Revenue Market Share by Country (2017-2028)

Figure 70. Brazil Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Argentina Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Middle East and Africa Circulating Tumor Cells (CTC) Sales Market Share by Type (2017-2028)

Figure 73. Middle East and Africa Circulating Tumor Cells (CTC) Sales Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Share by Country (2017-2028)

Figure 75. Turkey Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. UAE Circulating Tumor Cells (CTC) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz